Gregory M. Torre

SVP, Regulatory Affairs, NPS Pharmaceuticals (United States).

Companies

Galena BiopharmaCRO and SVP Dec 29, 2017 to Mar 15, 2018¹
NPS Pharmaceuticals (United States)SVP, Regulatory Affairs Mar 6, 2006 to Jul 18, 2007²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGalena Biopharma, CRO and SVP
2
SEC EDGARNPS Pharmaceuticals (United States), SVP, Regulatory Affairs